Q&A with Tom O'Regan, CEO at Madison Logic

MEDIA 7 | September 5, 2019

Q&A with Tom O'Regan
Tom O'Regan, CEO at Madison Logic is a global leader in account based marketing. In this role, O’Regan leads all company initiatives with an emphasis on positioning ActivateABMTM as the only truly global account based marketing platform built for B2B marketers.

Focused on driving Madison Logic momentum and enabling the Marketer to be the driving force for growth and change within the enterprise, O’Regan also sits on the Advisory Board of The Fiscal Times, both the Sales Executive Committee and B2B Operating Group at the IAB.

MEDIA 7: If I were to say to a bunch of people who know you, ‘Give me three adjectives that best describe you’, what would I hear?
TOM O'REGAN: 
Passionate, Optimistic, and Indefatigable

M7: Ovum has named Madison Logic a “Leader” in the Ovum Market Radar: Account-Based Marketing report. What factors have led Madison Logic to emerge as a leader in ABM?
TO'R:
Ovum recognized the strength of our ABM platform in achieving predictable growth among the fastest growing B2B organizations globally. Specifically, the ability to leverage intent data to target the right accounts, measure ABM effectiveness, shorten sales cycles, and accelerate growth. The Ovum report also highlights Madison Logic's data gateway that allows CRM and MAP platforms to connect seamlessly including Salesforce, Marketo, and Oracle Eloqua.


"AI will play a critical role in the dynamic account targeting, content personalization, and conversion metrics that will accelerate growth for B2B marketers."

M7: How will the bi-directional integration with Oracle Eloqua help Madison Logic to empower B2B marketers?
TO'R:
Communication between marketing and sales in addition to integrating with the leading CRM and MAP platforms are key factors for ABM success at large B2B organizations. With the Oracle Eloqua integration, Madison Logic seamlessly accesses target account lists to activate ABM Demand Generation and Advertising programs and transfers engagement data back into Eloqua for lead scoring. Joint clients can also take advantage of Journey Acceleration™, which personalizes messaging based on marketing funnel stage to increase the volume, velocity, and value of deals in the pipeline.


"Communication between marketing and sales in addition to integrating with the leading CRM and MAP platforms are key factors for ABM success at large B2B organizations."

M7: How do you see technology and artificial intelligence impacting the ABM landscape in the near future?
TO'R:
AI will play a critical role in the dynamic account targeting, content personalization, and conversion metrics that will accelerate growth for B2B marketers.



M7: Tom, your love for golf is well-known. Since when have you been playing golf and how do you manufacture time for it?
TO'R:
I’ve played golf since college and have met so many unbelievable people, explored so many amazing places around the world, and had incredible experiences enjoying the game of golf. With offices in NY, Boston, San Francisco, Seattle, London, Dublin, and Singapore, I have the opportunity to play with team members, partners, and clients once in a while. When I’m not working, I pick vacation spots partially on the quality of the links.

M7: What is your superpower?
TO'R:
I’d like to think I have a good eye for talent and finding people who have the skills, but more importantly I have the determination needed to grow and scale a business as a team.

ABOUT MADISON LOGIC

Madison Logic’s global account-based marketing (ABM) solution empowers B2B marketers to convert their best accounts faster. By integrating the ML Data Cloud with CRM and marketing automation platforms, intent data, and more than 20 other datasets, marketers execute a unified activation strategy across the funnel with ABM Advertising and ABM Demand Generation to align with sales, accelerate the buyer journey, and drive growth.

More C-Suite on deck

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Related News

HEALTH TECHNOLOGY,MEDICAL DEVICES

Predictive Health Solutions Technology Shows Promise in Combating Patient Appointment No-Shows

Predictive Health Solutions | December 06, 2022

With the Predictive Health Solutions Patient No-Show Predictor, providers now have a new tool in combatting patient no-shows. By leveraging the power of predictive analytics, the PHS Patient No-Show Predictor can also help reduce patient backlogs and long waitlists, improve operational efficiencies, promote better patient health outcomes, increase potential revenues, enhance patient care, and minimize caregiver burnout. Powered by SAS analytics software and co-developed by Pinnacle Solutions, the solution seamlessly integrates cutting edge technology into pre-existing daily operations, making it easy for healthcare staff to use. The solution identifies high-risk patients as well as potential key risk factors impacting a patient's ability to attend their appointment, such as weather, social determinants of health, or many other factors. Using the information provided, staff can quickly make informed decisions regarding intervention strategies that directly impact the patient's likelihood of attending their appointment and receiving the care they need. For example, staff may choose to offer alternative options to those with unreliable transportation or suggest afternoon appointments for those whose morning commute would be impacted by traffic delays. Teams may also choose to use the intelligence gathered to customize individual reminder protocols to maximize the impact and value of those existing tools. Data gathered can also be leveraged for strategic overbooking, as opposed to, for example, blindly scheduling same-day appointments. Patient no-shows cost the US and Canadian healthcare systems more than $150 billion annually, and those numbers are likely higher as a result of the COVID-19 pandemic. The ensuing funding shortages not only impact the bottom line, but also directly affect healthcare systems' ability to provide the desired level of care, which in many cases creating even greater accessibility and availability issues. For instance, revenue lost as a result of no-shows could be used to fund additional medical staff or provide the latest medical technologies and therapy sessions for patients in need. Predictive Health Solutions is a joint venture with Pinnacle Solutions, Inc. and the Center For Discovery, Innovation and Development an affiliate member of RWJBarnabas Health and a member of Children's Miracle Network Hospitals. PHS was established to improve access to healthcare, improve diagnostic algorithms, and enhance patient outcomes. PHS uses patient data and external sources to develop solutions that address healthcare needs better. Using machine learning algorithms and artificial intelligence, PHS helps organizations create optimal health for their communities.

Read More

FUTURE OF HEALTHCARE, DIGITAL HEALTHCARE

MarketVector Indexes™ Licenses the MVIS® Global Bionic Healthcare ESG Index to VanEck Europe

MVIS® Global Bionic Healthcare ESG Index | December 08, 2022

MarketVector IndexesTM announced the licensing of the MVIS® Global Bionic Healthcare ESG Index to underlie the VanEck Bionic Engineering UCITS ETF. The MVIS® Global Bionic Healthcare ESG Index includes companies that generate at least 50% of their revenue from medical, dental, or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue. “We have observed sound growth in the global bionics market which includes a range of niche healthcare solutions from medical implants to prostheses and bioprinting. These innovations in medical technology open new horizons to meet the rising needs of an aging population, significantly improve the quality of life for people with disabilities, and pave the way for the discovery of potentially life-saving treatments. The MVIS® Global Bionic Healthcare ESG Index offers an investable benchmark to track the leading companies in this industry.” Mirela Stefanova, Manager of Equity Operations at MarketVector The MVIS® Global Bionic Healthcare ESG Index is weighted by free float market capitalization and reviewed on a quarterly basis. The index is calculated in USD as a price index and a total return net index. Capping factors are applied to avoid overweighting of single index components. “The proportion of the elderly population is rising and with it the demand for technical solutions such as hearing and visual aids, pacemakers, artificial joints and the like that improve the quality of life in the old age,” says Martijn Rozemuller, CEO at VanEck Europe. “At the same time, increasingly available bionic tools are helping people with chronic diseases such as diabetes or functional disorders.” About MarketVector Indexes MarketVector IndexesTM is a regulated Benchmark Administrator in Europe, incorporated in Germany and registered with the Federal Financial Supervisory Authority (BaFin). MarketVector maintains indexes under the MarketVectorTM, MVIS® and BlueStar® names. With a mission to accelerate index innovation globally, MarketVector is best known for its broad suite of Thematic indexes, a long-running expertise in Hard Asset-linked Equity indexes, and its pioneering Digital Asset index family. MarketVector is proud to be in partnership with more than 25 Exchange Traded Product issuers and index fund managers in markets throughout the world, with approximately USD 26.99 billion in assets under management.

Read More

FUTURE OF HEALTHCARE,DIGITAL HEALTHCARE

MindMaze and Vibra Healthcare Partner to Deliver Advanced Digital Medicine and Neurorehabilitation Solutions for Patients from Clinic-to-Home

Vibra Healthcare | December 08, 2022

MindMaze, a global pioneer in the development of AI-driven neurotechnology, and Vibra Healthcare, a leader in post-acute hospital patient care, are excited to announce a partnership to deploy MindMaze’s digital health technology platform in-clinic and at-home for patients within select Vibra hospitals in Kentucky and California as a first step. MindMaze’s digital neurotherapeutic solutions are designed to help patients regain function through digitally-enabled assessments as well as behavioral training of holistic motor, cognitive and cardiovascular systems following Stroke/TBI, SCI, Parkinsons Disease and other neurological indications. This innovative partnership will enable clinicians to provide patients in the clinic and at home with interventions at dosage and intensity levels that are orders of magnitude higher than the current standard of care. MindMaze delivers novel software-based interventions and assessments for neurological diseases, as well as capabilities that monitor and measure patient function during the long-term management of chronic disease. The partnership will facilitate a large-scale roll-out of MindMaze solutions to improve care across in-patient, post-acute, community sub-acute and home-based care environments. The goal is to deliver a substantial increase in training and treatment for Vibra’s patients, as well as to offer seamless and coordinated transitions in care as patients are treated within the Vibra Healthcare System which operates and manages over 90 specialty hospitals as well as transitional care units/facilities in 19 states. The need for solutions that deliver superior outcomes—as well as those that support patients during the lifetime of their chronic condition—has never been greater. Nearly 100 million Americans are afflicted by a neurological disease, as reported in the Annals of Neurology, resulting more often than not in costly disability that can worsen over time. Nearly 50% of the total health burden in the United States is due to morbidity and disability. Consolidated studies have demonstrated that high dose, high intensity training can improve outcomes in traditionally hard-to-treat neurological indications. MindMaze believes that multimodal technology is fundamental to address the growing challenges faced by clinicians, patients and caregivers alike. “MindMaze is committed to redefining neuro recovery across the continuum of care through the development evidence-driven solutions for patients with serious neurological conditions. We are focused on providing clinicians with powerful, digitally-enabled, cutting-edge tools, while also empowering patients and their families with easy-to-use, engaging and accessible solutions. In Vibra we have found a world-class partner with both the commitment and true capability to deliver a step-change in brain health as well as meaningful improvements in patient outcomes.” Tej Tadi, Founder, Chairman & CEO of MindMaze “Vibra is committed to delivering the best possible care for our patients and the best value for our customers,” said Brad Hollinger, Founder, Chairman and CEO of Vibra Healthcare. “Our facilities have consistently ranked among the top-rated hospitals and rehabilitation facilities in the country, and we are always looking for ways to improve upon our incredibly high standards. We strongly believe that innovative technology in AI is the pioneering path forward to dramatically improve patient outcomes in the most cost-effective way. MindMaze has impressed our team not just with the power of their technological capabilities, but also with their experience in deploying real-world care pathways for patients with Stroke and other neurological conditions in countries around the world.” About MindMaze Founded in 2012, MindMaze is a global leader in brain technology and digital neurotherapeutic solutions for brain health and recovery. With a presence in over 15 countries, its mission is to accelerate the brain’s ability to recover, learn and adapt. The company has two core divisions – Healthcare and Labs – working collaboratively at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence. MindMaze Healthcare is advancing a universal platform for brain health with breakthrough solutions to some of the world’s most challenging problems in neurology, including stroke, Parkinson’s disease and Alzheimer’s disease. MindMaze Labs, the company’s R&D innovation hub, is focused on the future of human computing – working across multiple industries to innovate and build the next generation of human-machine interfaces. The company has offices in Lausanne, Baltimore, London, Paris and Mumbai. About the Vibra Healthcare Vibra Healthcare, LLC is a post-acute care provider based in Mechanicsburg, PA that is focused on the development, acquisition, and operation of freestanding specialty care hospitals, medical rehabilitation hospitals, and outpatient physical rehabilitation centers. Teams of highly trained specialists lead clinical programs at Vibra’s specialty hospitals for rehabilitating patients who suffer from strokes, multiple traumas, major orthopedic, neurologic, cardiac, and respiratory conditions. Vibra and its affiliates currently employ over 10,000 employees and own, operate, and manage over 90 specialty hospitals, transitional care units/facilities, and hospital-based outpatient physical therapy locations in 19 states.

Read More

HEALTH TECHNOLOGY,MEDICAL DEVICES

Predictive Health Solutions Technology Shows Promise in Combating Patient Appointment No-Shows

Predictive Health Solutions | December 06, 2022

With the Predictive Health Solutions Patient No-Show Predictor, providers now have a new tool in combatting patient no-shows. By leveraging the power of predictive analytics, the PHS Patient No-Show Predictor can also help reduce patient backlogs and long waitlists, improve operational efficiencies, promote better patient health outcomes, increase potential revenues, enhance patient care, and minimize caregiver burnout. Powered by SAS analytics software and co-developed by Pinnacle Solutions, the solution seamlessly integrates cutting edge technology into pre-existing daily operations, making it easy for healthcare staff to use. The solution identifies high-risk patients as well as potential key risk factors impacting a patient's ability to attend their appointment, such as weather, social determinants of health, or many other factors. Using the information provided, staff can quickly make informed decisions regarding intervention strategies that directly impact the patient's likelihood of attending their appointment and receiving the care they need. For example, staff may choose to offer alternative options to those with unreliable transportation or suggest afternoon appointments for those whose morning commute would be impacted by traffic delays. Teams may also choose to use the intelligence gathered to customize individual reminder protocols to maximize the impact and value of those existing tools. Data gathered can also be leveraged for strategic overbooking, as opposed to, for example, blindly scheduling same-day appointments. Patient no-shows cost the US and Canadian healthcare systems more than $150 billion annually, and those numbers are likely higher as a result of the COVID-19 pandemic. The ensuing funding shortages not only impact the bottom line, but also directly affect healthcare systems' ability to provide the desired level of care, which in many cases creating even greater accessibility and availability issues. For instance, revenue lost as a result of no-shows could be used to fund additional medical staff or provide the latest medical technologies and therapy sessions for patients in need. Predictive Health Solutions is a joint venture with Pinnacle Solutions, Inc. and the Center For Discovery, Innovation and Development an affiliate member of RWJBarnabas Health and a member of Children's Miracle Network Hospitals. PHS was established to improve access to healthcare, improve diagnostic algorithms, and enhance patient outcomes. PHS uses patient data and external sources to develop solutions that address healthcare needs better. Using machine learning algorithms and artificial intelligence, PHS helps organizations create optimal health for their communities.

Read More

FUTURE OF HEALTHCARE, DIGITAL HEALTHCARE

MarketVector Indexes™ Licenses the MVIS® Global Bionic Healthcare ESG Index to VanEck Europe

MVIS® Global Bionic Healthcare ESG Index | December 08, 2022

MarketVector IndexesTM announced the licensing of the MVIS® Global Bionic Healthcare ESG Index to underlie the VanEck Bionic Engineering UCITS ETF. The MVIS® Global Bionic Healthcare ESG Index includes companies that generate at least 50% of their revenue from medical, dental, or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue. “We have observed sound growth in the global bionics market which includes a range of niche healthcare solutions from medical implants to prostheses and bioprinting. These innovations in medical technology open new horizons to meet the rising needs of an aging population, significantly improve the quality of life for people with disabilities, and pave the way for the discovery of potentially life-saving treatments. The MVIS® Global Bionic Healthcare ESG Index offers an investable benchmark to track the leading companies in this industry.” Mirela Stefanova, Manager of Equity Operations at MarketVector The MVIS® Global Bionic Healthcare ESG Index is weighted by free float market capitalization and reviewed on a quarterly basis. The index is calculated in USD as a price index and a total return net index. Capping factors are applied to avoid overweighting of single index components. “The proportion of the elderly population is rising and with it the demand for technical solutions such as hearing and visual aids, pacemakers, artificial joints and the like that improve the quality of life in the old age,” says Martijn Rozemuller, CEO at VanEck Europe. “At the same time, increasingly available bionic tools are helping people with chronic diseases such as diabetes or functional disorders.” About MarketVector Indexes MarketVector IndexesTM is a regulated Benchmark Administrator in Europe, incorporated in Germany and registered with the Federal Financial Supervisory Authority (BaFin). MarketVector maintains indexes under the MarketVectorTM, MVIS® and BlueStar® names. With a mission to accelerate index innovation globally, MarketVector is best known for its broad suite of Thematic indexes, a long-running expertise in Hard Asset-linked Equity indexes, and its pioneering Digital Asset index family. MarketVector is proud to be in partnership with more than 25 Exchange Traded Product issuers and index fund managers in markets throughout the world, with approximately USD 26.99 billion in assets under management.

Read More

FUTURE OF HEALTHCARE,DIGITAL HEALTHCARE

MindMaze and Vibra Healthcare Partner to Deliver Advanced Digital Medicine and Neurorehabilitation Solutions for Patients from Clinic-to-Home

Vibra Healthcare | December 08, 2022

MindMaze, a global pioneer in the development of AI-driven neurotechnology, and Vibra Healthcare, a leader in post-acute hospital patient care, are excited to announce a partnership to deploy MindMaze’s digital health technology platform in-clinic and at-home for patients within select Vibra hospitals in Kentucky and California as a first step. MindMaze’s digital neurotherapeutic solutions are designed to help patients regain function through digitally-enabled assessments as well as behavioral training of holistic motor, cognitive and cardiovascular systems following Stroke/TBI, SCI, Parkinsons Disease and other neurological indications. This innovative partnership will enable clinicians to provide patients in the clinic and at home with interventions at dosage and intensity levels that are orders of magnitude higher than the current standard of care. MindMaze delivers novel software-based interventions and assessments for neurological diseases, as well as capabilities that monitor and measure patient function during the long-term management of chronic disease. The partnership will facilitate a large-scale roll-out of MindMaze solutions to improve care across in-patient, post-acute, community sub-acute and home-based care environments. The goal is to deliver a substantial increase in training and treatment for Vibra’s patients, as well as to offer seamless and coordinated transitions in care as patients are treated within the Vibra Healthcare System which operates and manages over 90 specialty hospitals as well as transitional care units/facilities in 19 states. The need for solutions that deliver superior outcomes—as well as those that support patients during the lifetime of their chronic condition—has never been greater. Nearly 100 million Americans are afflicted by a neurological disease, as reported in the Annals of Neurology, resulting more often than not in costly disability that can worsen over time. Nearly 50% of the total health burden in the United States is due to morbidity and disability. Consolidated studies have demonstrated that high dose, high intensity training can improve outcomes in traditionally hard-to-treat neurological indications. MindMaze believes that multimodal technology is fundamental to address the growing challenges faced by clinicians, patients and caregivers alike. “MindMaze is committed to redefining neuro recovery across the continuum of care through the development evidence-driven solutions for patients with serious neurological conditions. We are focused on providing clinicians with powerful, digitally-enabled, cutting-edge tools, while also empowering patients and their families with easy-to-use, engaging and accessible solutions. In Vibra we have found a world-class partner with both the commitment and true capability to deliver a step-change in brain health as well as meaningful improvements in patient outcomes.” Tej Tadi, Founder, Chairman & CEO of MindMaze “Vibra is committed to delivering the best possible care for our patients and the best value for our customers,” said Brad Hollinger, Founder, Chairman and CEO of Vibra Healthcare. “Our facilities have consistently ranked among the top-rated hospitals and rehabilitation facilities in the country, and we are always looking for ways to improve upon our incredibly high standards. We strongly believe that innovative technology in AI is the pioneering path forward to dramatically improve patient outcomes in the most cost-effective way. MindMaze has impressed our team not just with the power of their technological capabilities, but also with their experience in deploying real-world care pathways for patients with Stroke and other neurological conditions in countries around the world.” About MindMaze Founded in 2012, MindMaze is a global leader in brain technology and digital neurotherapeutic solutions for brain health and recovery. With a presence in over 15 countries, its mission is to accelerate the brain’s ability to recover, learn and adapt. The company has two core divisions – Healthcare and Labs – working collaboratively at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence. MindMaze Healthcare is advancing a universal platform for brain health with breakthrough solutions to some of the world’s most challenging problems in neurology, including stroke, Parkinson’s disease and Alzheimer’s disease. MindMaze Labs, the company’s R&D innovation hub, is focused on the future of human computing – working across multiple industries to innovate and build the next generation of human-machine interfaces. The company has offices in Lausanne, Baltimore, London, Paris and Mumbai. About the Vibra Healthcare Vibra Healthcare, LLC is a post-acute care provider based in Mechanicsburg, PA that is focused on the development, acquisition, and operation of freestanding specialty care hospitals, medical rehabilitation hospitals, and outpatient physical rehabilitation centers. Teams of highly trained specialists lead clinical programs at Vibra’s specialty hospitals for rehabilitating patients who suffer from strokes, multiple traumas, major orthopedic, neurologic, cardiac, and respiratory conditions. Vibra and its affiliates currently employ over 10,000 employees and own, operate, and manage over 90 specialty hospitals, transitional care units/facilities, and hospital-based outpatient physical therapy locations in 19 states.

Read More

Spotlight

Madison Logic

Madison Logic

Madison Logic’s global account-based marketing (ABM) solution empowers B2B marketers to convert their best accounts faster. By integrating the ML Data Cloud with CRM and marketing automation platforms, intent data, and more than 20 other datasets, marketers execute a unified activation strategy acro...

Events

Resources